Futura Medical (GB:FUM) has released an update.
Futura Medical PLC, the healthcare company focused on sexual health products, has awarded 2,176,000 share options to its employees and directors, with 905,000 of these granted to top executives. These options are exercisable between April 2027 and March 2034 at a price of 35.50p, contingent upon achieving certain performance milestones. The move aligns with the company’s long-term incentive plans and highlights its commitment to its lead product, Eroxon, a topical gel for erectile dysfunction.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.
